HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Liu Selected Research

4- piperazin- 1- yl- 6,7- dihydro- 5H- benzo(6,7)cyclohepta(1,2- d)pyrimidin- 2- ylamine

5/2009In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Liu Research Topics

Disease

131Neoplasms (Cancer)
07/2022 - 01/2000
44Infections
03/2022 - 01/2000
31Inflammation (Inflammations)
06/2022 - 11/2000
23Breast Neoplasms (Breast Cancer)
02/2022 - 09/2000
19Neoplasm Metastasis (Metastasis)
02/2022 - 03/2001
17Stomach Neoplasms (Stomach Cancer)
05/2022 - 02/2001
15Pain (Aches)
04/2022 - 12/2000
15Ischemia
04/2017 - 03/2001
13Necrosis
01/2022 - 12/2000
13Insulin Resistance
08/2019 - 05/2000
12Fibrosis (Cirrhosis)
07/2019 - 05/2000
10Carcinoma (Carcinomatosis)
02/2019 - 03/2000
10Hypoxia (Hypoxemia)
01/2018 - 05/2000
9Lung Neoplasms (Lung Cancer)
04/2022 - 04/2000
9Melanoma (Melanoma, Malignant)
10/2021 - 01/2001
9Diabetes Mellitus
04/2020 - 01/2000
9Hepatocellular Carcinoma (Hepatoma)
01/2018 - 04/2007
9Carcinogenesis
12/2017 - 09/2006
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 04/2000
8Ovarian Neoplasms (Ovarian Cancer)
05/2021 - 05/2008
8Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2021 - 11/2009
8Sepsis (Septicemia)
01/2021 - 12/2009
8Stroke (Strokes)
12/2018 - 01/2000
7Glioma (Gliomas)
01/2022 - 08/2000
7Body Weight (Weight, Body)
10/2021 - 02/2001
7Hemorrhage
01/2021 - 01/2008
7Multiple Myeloma
05/2020 - 02/2014
7Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 11/2001
7Lymphoma (Lymphomas)
12/2019 - 06/2000
7Parkinson Disease (Parkinson's Disease)
06/2018 - 12/2001
7Esophageal Squamous Cell Carcinoma
02/2018 - 02/2009
7Wounds and Injuries (Trauma)
01/2018 - 06/2001
6Rheumatoid Arthritis
10/2021 - 12/2000
6Chronic Hepatitis B
07/2019 - 09/2001
6Adenocarcinoma
09/2018 - 01/2014
6Seizures (Absence Seizure)
01/2007 - 01/2000
6Status Epilepticus (Complex Partial Status Epilepticus)
01/2006 - 01/2000
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2021 - 08/2011
5Nasopharyngeal Carcinoma
11/2020 - 12/2001
5Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 03/2010
5Osteoporosis
05/2019 - 03/2012
5Thrombosis (Thrombus)
12/2018 - 10/2010
5Hypertension (High Blood Pressure)
12/2017 - 01/2000
5Type 2 Diabetes Mellitus (MODY)
06/2015 - 01/2008
4B-Cell Lymphoma (Lymphoma, B Cell)
06/2022 - 06/2000

Drug/Important Bio-Agent (IBA)

57Proteins (Proteins, Gene)FDA Link
06/2022 - 04/2000
26Pharmaceutical PreparationsIBA
06/2022 - 01/2000
24Messenger RNA (mRNA)IBA
04/2022 - 01/2000
15CytokinesIBA
01/2019 - 05/2000
14DNA (Deoxyribonucleic Acid)IBA
06/2022 - 06/2000
14Therapeutic UsesIBA
03/2022 - 06/2000
14Insulin (Novolin)FDA Link
09/2020 - 05/2000
13MicroRNAs (MicroRNA)IBA
06/2021 - 03/2012
13Biological ProductsIBA
05/2021 - 06/2000
13Glucose (Dextrose)FDA LinkGeneric
09/2020 - 09/2008
13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 01/2000
12Small Interfering RNA (siRNA)IBA
04/2022 - 08/2010
12Interleukin-6 (Interleukin 6)IBA
06/2020 - 01/2000
11Biomarkers (Surrogate Marker)IBA
02/2021 - 03/2001
11AcidsIBA
10/2018 - 01/2000
8Transcription Factors (Transcription Factor)IBA
01/2019 - 09/2005
7EnzymesIBA
03/2022 - 01/2001
7LipopolysaccharidesIBA
07/2021 - 01/2000
7AntibodiesIBA
12/2019 - 10/2000
7Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 06/2000
7AntigensIBA
10/2018 - 07/2001
7Interleukin-4 (Interleukin 4)IBA
01/2018 - 06/2000
7Cisplatin (Platino)FDA LinkGeneric
01/2015 - 11/2000
6CholesterolIBA
10/2021 - 09/2008
6Antiviral Agents (Antivirals)IBA
02/2021 - 09/2001
6salicylhydroxamic acid (SHAM)IBA
06/2020 - 08/2001
6Estrogen ReceptorsIBA
04/2017 - 08/2000
5Folic Acid (Vitamin M)FDA LinkGeneric
12/2021 - 10/2020
5AntioxidantsIBA
10/2021 - 01/2005
5Long Noncoding RNAIBA
01/2021 - 10/2018
5CalciumIBA
10/2020 - 09/2001
5CreatinineIBA
06/2020 - 07/2013
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2019 - 01/2000
5RNA (Ribonucleic Acid)IBA
05/2019 - 07/2001
5Blood Glucose (Blood Sugar)IBA
05/2019 - 01/2000
5Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019 - 11/2001
5Protein Isoforms (Isoforms)IBA
02/2018 - 02/2001
5CollagenIBA
01/2018 - 01/2001
5ParaffinIBA
07/2017 - 04/2000
5Immunoglobulin A (IgA)IBA
01/2017 - 07/2014
5Immunoglobulin G (IgG)IBA
11/2016 - 07/2014
5Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2012 - 02/2000
5Kainic Acid (Kainate)IBA
01/2007 - 01/2000
4ImmunosorbentsIBA
03/2022 - 11/2008

Therapy/Procedure

56Therapeutics
03/2022 - 01/2000
21Drug Therapy (Chemotherapy)
07/2022 - 02/2001
16Radiotherapy
07/2022 - 03/2001
10Hematopoietic Stem Cell Transplantation
02/2019 - 04/2015
9Transplantation
12/2021 - 06/2013
9Neoadjuvant Therapy
01/2021 - 01/2014
8Lasers (Laser)
08/2013 - 01/2000
7Ligation
06/2020 - 05/2000
6Chemoradiotherapy
01/2022 - 04/2010
6Immunotherapy
12/2021 - 01/2001
6Length of Stay
04/2020 - 02/2014